Free Republic

"Empire State considers being a minority a health 'risk factor' due to 'longstanding systemic health and social inequities' The state of New York said it will prioritize non-White people in the distribution of COVID-19 treatments in short supply. New York’s Department of Health released a document detailing its plan to distribute the treatments, such as monoclonal antibody treatment and antiviral pills. The plan includes a section on eligibility for the scarce antiviral pills that people must meet to receive the treatment, including a line stating a person needs to have "a medical condition or other factors that increase their risk...

The New York State Department of Health has chosen a very peculiar and unconstitutional way to allocate scarce resources. Martin Luther King, Jr., dreamed of a world in which his children would be judged not by the color of their skin but by the content of their character. New York State’s Department of Health has effectively said that the color of a person’s skin is the only thing that matters. It has explicitly announced that, because of a shortage of monoclonal antibody treatments, the state will be rationing what supplies it has...and White people need not apply. Normally, when there’s...

White people infected with COVID in New York State - the hardest hit state in the country - are in jeopardy of being turned away from potential lifesaving treatments in favor of other more at-risk races because of a national shortage of two promising types of medical treatments.

The state of New York said it will prioritize non-White people in the distribution of COVID-19 treatments in short supply. New York’s Department of Health released a document detailing its plan to distribute the treatments, such as monoclonal antibody treatment and antiviral pills. The plan includes a section on eligibility for the scarce antiviral pills that people must meet to receive the treatment, including a line stating a person needs to have "a medical condition or other factors that increase their risk for severe illness." One such "risk factor" is being a race or ethnicity that is not White due...

Joe Biden is cutting off supplies of a medical therapy that helps people fend off COVID and keeps them from going to the hospital and possibly dying. Monoclonal antibodies are a man-made therapy to fight off the COVID infection.You’ve got to hand it to Biden: Cutting off likely life-saving medication is one way to ingratiate yourself with your voters. Yeah, that’s the ticket.This week, his minions in public health decided to cut off – “pause” was the word they used – the allocation of certain monoclonal antibodies to the states using them.And that’s not nothing.The operator of two Maryland monoclonal...

The actions that the Biden administration just took to restrict monoclonal antibody treatments are going to get people killed, says a medical director in Maryland.As we noted yesterday, the CDC made a rather large mistake when they claimed that more than 73 percent of the cases of COVID in the nation were Omicron cases in the week ending Dec. 18. The number was only 22.5 percent of the cases at that point.Why was that important? Because then the Office of the Assistant Secretary for Preparedness and Response halted the allocation of two antibody treatments made by Regeneron and Eli Lilly...

Florida state surgeon general: 'The federal government is actively preventing the effective distribution of monoclonal antibody treatments in the U.S.' Asks why Biden administration is limiting such an important Covid treatment. From @jayobtv: pic.twitter.com/9MyVKqRdXE— Byron York (@ByronYork) December 29, 2021

WASHINGTON (AP) — As strained U.S. hospitals brace for a new surge of COVID-19 cases caused by the fast-spreading omicron variant, doctors are warning of yet another challenge: the two standard drugs they’ve used to fight infections are unlikely to work against the new strain. For more than a year antibody drugs from Regeneron and Eli Lilly have been the go-to treatments for early COVID-19, thanks to their ability to head off severe disease and keep patients out of the hospital. But both drugmakers recently warned that laboratory testing suggests their therapies will be much less potent against omicron, which...

Of the eight approved or authorized antibodies, all but sotrovimab completely or almost completely lost their neutralizing activity against the Omicron pseudovirus. A cocktail of cilgavimab and tixagevimab had a reduced potency of 200-fold. Sotrovimab, conversely, shows a drop of 3-fold drop in neutralization potency.

Mark Levin says he had Covid last week... despite being vaccinated with J&J and constant use of masks. Praises DeSantis for monoclonal antibody program.

WASHINGTON (AP) — Federal health officials on Wednesday authorized a new COVID-19 antibody drug for people with serious health problems or allergies who can’t get adequate protection from vaccination. Antibody drugs have been a standard treatment for treating COVID-19 infections for over a year. But the AstraZeneca antibody drug cleared by the Food and Drug Administration is different. It’s the first intended for long-term prevention against COVID-19 infection, rather than a short-term treatment. People who could benefit from the antibody drug include cancer patients, organ transplant recipients and people taking immune-suppressing drugs....the required two antibody injections may be effective at...

Sometimes, it is good to be Pfizer — especially when there is a pandemic they can leverage to their advantage to create a monopolistic market-share of a vaccine that government literally buys from them and markets to patients, or when they can manipulate the government into protecting their data for another half-century. Other times, it isn’t so good to be Pfizer, as was the case with Project Veritas’ story which showed Pfizer employees contradicting the government’s vaccine narrative.And yet other times, Pfizer runs into a situation so dire, it could destroy their business for a decade to come. In pharmaceuticals,...

We’ve seen some high profile people like Joe Rogan tout the benefits of monoclonal antibody treatment.Some have been raising a question over the past day or so about the criteria it takes to get the treatment for COVID, after reports that treatment facilities allegedly were using race as one possible qualifier to get the treatment in Texas. One report allegedly involved the Texas Health and Human Services Infusion Hotline.The reason is that some medical facilities are making being Hispanic/black as one of the things that qualifies you to get the monoclonal antibody treatment. Here’s a list from one medical center...

Regeneron Pharmaceuticals Inc announced on Monday that its antibody cocktail can severely slash the risk of being infected with COVID-19 for up to eight months. ... ...Late-stage trial data showed a single dose can lower the risk of contracting Covid by 81.6 percent between two and six-months after the cocktail is administered... ...'These results demonstrate that REGEN-COV has the potential to provide long-lasting immunity from SARS-CoV-2 infection, a result particularly important to those who do not respond to COVID-19 vaccines including people who are immunocompromised.' .. ...The new trial data, released today, looked at the antibody cocktail's efficacy between two...

...Currently, over 1 million doses of monoclonal antibody infusions have been given in the United States. Use of monoclonal antibodies gained steam during the delta variant surge over the summer when Florida and other states opened clinics to administer the drugs in an attempt to keep sick people out of overwhelmed hospitals. Monoclonal antibodies have been authorized for post-exposure prophylaxis, meaning they are used shortly after someone tests positive in order to prevent progression to severe disease. The antibodies range in effectiveness depending on type, but some have been shown in to reduce COVID-related hospitalization or death by up to...

Tennessee is restricting the use of monoclonal antibody treatments to people who are not vaccinated against COVID-19. In a statement to The Hill, a spokesperson for the Tennessee Department of Health explained that the state is following guidelines from the National Institutes of Health...amid a nationwide shortage. ...The NIH updated its guidelines on Sept. 3 to advise prioritizing monoclonal antibodies for those who are either unvaccinated or partially vaccinated and are at high risk of progressing to severe COVID-19. NIH also advised prioritizing vaccinated individuals who are “not expected to amount an adequate immune response,” such as immunocompromised individuals....

TALLAHASSEE (CBSMiami/NSF) — Gov. Ron DeSantis announced Thursday that the state has begun purchasing doses of a monoclonal antibody treatment directly from the pharmaceutical company GlaxoSmithKline, after the federal government last week took control of distribution of the COVID-19 treatments produced by other companies. DeSantis said the first purchase was for 3,000 doses of the drug sotrovimab, which was given emergency-use authorization by the U.S. Food and Drug Administration in May. The governor said last week that he would pursue a direct-purchasing agreement with GlaxoSmithKline, as the state is unable to directly buy doses of Regeneron’s monoclonal antibody treatment. Monoclonal...

In figuring out the trouble with vaccine mandates, it's worthwhile to consider the opposite yet successful treatment protocols used in India and Sweden. Both approaches by these two very different countries have proven to be effective in taming the COVID beast.India originally prescribed hydroxychloroquine (HCQ) at the onset of the pandemic with great success. It then switched to its new and more potent COVID kit containing ivermectin to conquer the more contagious delta and subsequent variants. In so doing, India continuously maintained an insignificant daily death rate per million except for a brief increase when the delta variant first appeared....

On Sept. 14, the Biden administration announced that the feds would be cutting the number of monoclonal treatments per week in the southern states and reallocating them as part of a broader plan to start rationing the treatments. For example, in Florida, HHS issued an allocation for the week of Sept. 13 of 3,100 doses of BAM/ETE treatments and 27,850 doses of REGN-COV. As Florida Gov. Ron DeSantis said in a press conference last week, this would effectively reduce Florida's allocation by 50%. The federal agency did this without any warning or indication that there was a shortage. Then, last...

Florida Governor Ron DeSantis said that he was “very, very concerned” with Democrat President Joe Biden’s decision to restrict the distribution of monoclonal antibodies to states amid a surge in demand by states in the South. “Just last week on September 9th, President Joe Biden said that his administration would be increasing shipments of monoclonal antibodies in September by 50%, and yet on September 13th, HHS announced that it was seizing control of the monoclonal antibody supply and that it would control distribution, and then on September 14th, the announcement was more than 50% of the monoclonal antibodies that had...